CIRCADIN cpr ret 2 mg 21 pce

7680593110015 CH-59311 N05CH01 01.03.1.
CIRCADIN cpr ret 2 mg 21 pce
CIRCADIN cpr ret 2 mg 21 pce
CIRCADIN cpr ret 2 mg 21 pce
1 / 3
google

Details

Product number
5931101
CPT
-
Packaging group
21
Unit
Tablette(n)
Composition
melatoninum 2 mg, ammonio methacrylatis copolymerum B, calcii hydrogenophosphas dihydricus, lactosum monohydricum 80 mg, silica colloidalis anhydrica, talcum, magnesii stearas, pro compresso.

Articles (1)

Circadin, Retardtabletten
Tabletten
21
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
19/02/2021
Patient information leaflet
Français
19/02/2021
Patient information leaflet
Italien
19/02/2021
Professional SmPC
Allemand
01/10/2020
Professional SmPC
Français
01/10/2020
Professional SmPC
Italien
01/10/2020

Detailed composition

Substance Quantity Type Category
(N/A)
2.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
80.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

NEURIM PHARMACEUTICALS AG

6312 Steinhausen

Authorization information

Swissmedic authorization number
59311
Drug name
Circadin, Retardtabletten
Galenic form
RETT
ATC Code
N05CH01
Authorization status
Z
Dispensation category
B
First authorization
09/11/2009
Authorization expiration date
31/12/9999
IT number
01.03.1.
Domain
Human medicine
Field of application
Schlafmittel

Packaging details

Description (FR)
CIRCADIN cpr ret 2 mg 21 pce
Description (DE)
CIRCADIN Ret Tabl 2 mg 21 Stk
Market launch
09/11/2009
Narcotic (BTM)
No